SARS-COV2 INFECTION
Clinical trials for SARS-COV2 INFECTION explained in plain language.
Never miss a new study
Get alerted when new SARS-COV2 INFECTION trials appear
Sign up with your email to follow new studies for SARS-COV2 INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a single infusion of COVID-Fighting antibodies keep High-Risk patients out of the hospital?
Disease control TerminatedThis study tests whether a single infusion of anti-COVID-19 hyperimmune immunoglobulin (hIVIG) can improve symptoms and prevent hospitalization in adults recently diagnosed with COVID-19 who are not sick enough to be hospitalized. Participants are at higher risk due to age (55+) …
Matched conditions: SARS-COV2 INFECTION
Phase: PHASE3 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 16, 2026 12:48 UTC
-
Could a simple COVID pill ward off Long-Haul symptoms?
Prevention OngoingThis study tests whether taking Paxlovid early in a COVID-19 infection can prevent long-COVID. About 2,000 adults aged 18-64 with a recent positive test and symptoms will receive either Paxlovid or a placebo. Researchers will check for long-COVID symptoms like fatigue, shortness …
Matched conditions: SARS-COV2 INFECTION
Phase: PHASE3 • Sponsor: Haukeland University Hospital • Aim: Prevention
Last updated Jun 16, 2026 12:50 UTC